chikungunya virus

Valneva Launches 60M Euro Share Placement for Vaccine Development
Tip Ranks
Fri, 09/13/24 - 11:06 am
Valneva
funding
vaccines
chikungunya virus
Shigella
Zika virus
Valneva gets $41m grant to roll out chikungunya vaccine
Pharmaphorum
Mon, 07/22/24 - 11:28 am
Valneva
funding
CEPI
vaccines
chikungunya virus
After coming up short in COVID, Valneva focuses on chikungunya vaccine launch
Fierce Pharma
Fri, 04/19/24 - 11:22 am
Valneva
vaccines
chikungunya virus
COVID-19
CDC Advisory Panel Backs Valneva’s Chikungunya Vaccine for Certain Groups
BioSpace
Thu, 02/29/24 - 10:58 am
CDC
Valneva
vaccines
chikungunya virus
Valneva reports latest findings from chikungunya vaccine trial
Clinical Trials Arena
Mon, 12/4/23 - 09:33 am
Valneva
chikungunya virus
Ixchiq
clinical trials
Valneva single-dose chikungunya vaccine poised to ‘revolutionize’ global health
Biopharma Reporter
Thu, 11/16/23 - 11:38 am
Valneva
vaccines
Ixchiq
FDA
chikungunya virus
FDA approves Valneva's chikungunya vaccine
Reuters
Thu, 11/9/23 - 11:39 pm
Valneva
vaccines
chikungunya virus
FDA
Ixchiq
Valneva reports data from chikungunya vaccine trial in adolescents
Clinical Trials Arena
Mon, 08/28/23 - 10:44 am
Valneva
clinical trials
VLS1553
chikungunya virus
FDA, seeking time for phase 4 talks, delays decision on Valneva's chikungunya vaccine by 3 months
Fierce Biotech
Mon, 08/14/23 - 10:13 am
Valneva
vaccines
FDA
chikungunya virus
Bavarian Nordic goes 2 for 2 in pivotal chikungunya vaccine trials, teeing up filing to rival Valneva
Fierce Biotech
Mon, 08/7/23 - 10:16 am
Bavarian Nordic
chikungunya virus
vaccine
clinical trials
Valneva
Bavarian Nordic bites back in chikungunya vaccine race, hitting phase 3 goal to stay on Valneva's heels
Fierce Biotech
Tue, 06/20/23 - 10:10 am
Bavarian Nordic
clinical trials
chikungunya virus
vaccines
Valneva
Valneva Reports Strong Phase III Chikungunya Vaccine Data After Merck’s Exit from Race
BioSpace
Tue, 06/13/23 - 11:27 am
Valneva
chikungunya virus
clinical trials
vaccines
FDA accepts Valneva’s chikungunya vaccine BLA for priority review
Pharmaceutical Business Review
Tue, 02/21/23 - 10:10 am
Valneva
chikungunya virus
vaccine
VLS1553
Emergent scores a DoD award to evaluate its chikungunya vaccine in the field
Endpoints
Thu, 11/17/22 - 12:12 pm
Emergent BioSolutions
chikungunya virus
Department of Defense
government contracts
vaccines
Merck, Emergent, Affinivax and Ocugen Level Up in Vaccine Development
BioSpace
Tue, 06/21/22 - 12:02 pm
Merck
Emergent BioSolutions
Affinivax
Ocugen
vaccines
chikungunya virus
pneumococcal disease
COVID-19
Valneva Successfully Completes Lot-to-Lot Consistency Trial for its Single-Shot Chikungunya Vaccine Candidate
BioSpace
Wed, 05/25/22 - 10:29 am
Valneva
vaccines
clinical trials
VLA1553
chikungunya virus
Moderna scraps lead mRNA chikungunya candidate after phase 1, slowing push beyond prophylactic vaccines
Fierce Biotech
Fri, 11/5/21 - 09:44 am
Moderna Therapeutics
vaccines
MRNA
chikungunya virus
clinical trials
Chikungunya vaccine candidate enters Phase 2/3 trial
BioPharma Dive
Thu, 08/26/21 - 08:48 pm
vaccines
Bharat Biotech
clinical trials
chikungunya virus
Valneva’s chikungunya vaccine reports positive topline data from Phase 3 trial
Biopharma Reporter
Thu, 08/5/21 - 11:08 am
Valneva
vaccines
chikungunya virus
clinical trials
Emergent BioSolutions Announces Positive Two-Year Persistence Data From Phase 2 Study Evaluating CHIKV VLP, the Company’s Chikungunya Virus Virus-Like Particle Vaccine Candidate
Drugs.com
Mon, 05/31/21 - 07:04 pm
Emergent BioSolutions
clinical trials
vaccines
chikungunya virus

Pages